Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

Anthem Biosciences IPO receives tepid response, retail investors show interest, SBI Securities recommends long-term ...

JM Financial Limited is acting as the book-running lead manager to the issue, and KFin Technologies Limited is the registrar.

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

Anthem Biosciences Limited's ₹3,395 crore initial public offering (IPO) witnessed a subdued response on its first day, with only 0.19 times subscription by midday Monday.

Smartworks Coworking’s IPO saw a decent interest from retail and non-institutional investors by Day 3, while Astec ...

Ahead of the initial share sale opening for public subscription, the unlisted shares of Anthem Biosciences were trading at ...

Anthem Biosciences is selling its shares in the price band of Rs 540-570, which could be applied for a minimum of 26 shares and its multiples to raise a total of Rs 3,395 crore between July 14-16.

The company offers integrated services across the drug discovery, development, and manufacturing lifecycle for both NCEs and ...

The issue is entirely an offer for sale of 5.96 crore shares, from its promoters, investors, and other selling shareholders.

Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on ...